Evidence map›Paper›PMID 40922988›Full record

ReviewInternational journal of nanomedicine2025

Recent Progress in Peptide-Based Fluorescent Probes Biomedical Applications: A Review.

Xue Zhong, Yuanlong Xie, Yuen Chen, Yushen Lu, Mingming Hou

Abstract readReview
In one paragraph

Review in International journal of nanomedicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Xue Zhong *Department of Spine Surgery and Musculoskeletal Tumor, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, People's Republic of China.ORCID 0009-0005-8674-5963
Yuanlong Xie *Department of Spine Surgery and Musculoskeletal Tumor, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, People's Republic of China.ORCID 0000-0001-6788-8786
Yuen ChenSecond Clinical College, Wuhan University, Wuhan, Hubei, People's Republic of China.
Yushen LuSecond Clinical College, Wuhan University, Wuhan, Hubei, People's Republic of China.
Mingming HouDepartment of Orthopedics, Honghui Hospital, Xi'an Jiaotong University, Xi'an, Shaanxi, People's Republic of China.ORCID 0009-0005-2255-3874

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Peptide-based fluorescent probes have found widespread applications in biomedical research, including bio-imaging, disease diagnosis, drug discovery, and image-guided surgery. Their favorable properties-such as small molecular size, low toxicity, minimal immunogenicity, and high targeting specificity-have contributed to their growing utility in both basic research and translational medicine. This review provides a comprehensive overview of recent advances in peptide-based fluorescent probes, emphasizing design strategies, biological targets, and diverse functional applications. Key areas of focus include the integration of molecular targeting with imaging capabilities, the emergence of multimodal imaging techniques, and the development of activatable probes responsive to specific biological stimuli. Applications are discussed in the context of tumor cell membrane recognition, subcellular organelle targeting, non-cancer disease diagnosis, and detection of both metal ions and non-metal ions. Notably, responsive probes for reactive oxygen species (ROS) and other biologically relevant non-metal ions are also highlighted, underscoring their diagnostic and therapeutic potential. The review also addresses key limitations-such as poor in vivo stability, limited targeting accuracy, and delivery efficiency-and outlines future directions including smart peptide probe platforms, self-reporting systems, and high-throughput screening based on peptide libraries to accelerate next-generation probe development.

Indexed as

Fluorescent DyesPeptidesAnimalsHumansNeoplasmsOptical ImagingReactive Oxygen SpeciesFluorescent DyesPeptidesReactive Oxygen Speciesbio-imagingdrug-targeted deliverymetal ion detectionmultimodal imagingorganelle targetingpeptide fluorescent probestumor cell identification

Identifiers

PMID40922988
PMCPMC12414470

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.